ÂÜÀòÂÒÂ×

Federico Mensa has a strong background in clinical development and medical leadership in the pharmaceutical industry. Federico currently holds the position of Vice President of Clinical Development Infectious Diseases at BioNTech SE. Prior to this role, Federico served as the Vice President of Clinical Development Infectious Diseases at Atea Pharmaceuticals, Inc. Federico also worked at AbbVie, where they held multiple roles, including Group Medical Director and Global Development Lead for various programs such as SARS-CoV2 Antibodies, HIV, and HCV. Before their time at AbbVie, Federico gained experience at Boehringer Ingelheim as a Global Sr. Clinical Program Leader and Regional Medical Monitor. Federico began their career as a Research Trainee at The Mount Sinai Hospital.

Federico Mensa's education history includes pursuing a Medical Doctor (MD) degree at the University of Buenos Aires. Additionally, they completed a Residence/Fellowship in Internal Medicine and Infectious Diseases at the same university, specializing in the field of Infectious Diseases.